These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 25445532)

  • 1. Nanocarrier improves the bioavailability, stability and antitumor activity of camptothecin.
    Tang XJ; Han M; Yang B; Shen YQ; He ZG; Xu DH; Gao JQ
    Int J Pharm; 2014 Dec; 477(1-2):536-45. PubMed ID: 25445532
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hydrophobically modified glycol chitosan nanoparticles-encapsulated camptothecin enhance the drug stability and tumor targeting in cancer therapy.
    Min KH; Park K; Kim YS; Bae SM; Lee S; Jo HG; Park RW; Kim IS; Jeong SY; Kim K; Kwon IC
    J Control Release; 2008 May; 127(3):208-18. PubMed ID: 18336946
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro and in vivo evaluation of SN-38 nanocrystals with different particle sizes.
    Chen M; Li W; Zhang X; Dong Y; Hua Y; Zhang H; Gao J; Zhao L; Li Y; Zheng A
    Int J Nanomedicine; 2017; 12():5487-5500. PubMed ID: 28814865
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Free paclitaxel loaded PEGylated-paclitaxel nanoparticles: preparation and comparison with other paclitaxel systems in vitro and in vivo.
    Lu J; Chuan X; Zhang H; Dai W; Wang X; Wang X; Zhang Q
    Int J Pharm; 2014 Aug; 471(1-2):525-35. PubMed ID: 24858391
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preparation and antitumor study of camptothecin nanocrystals.
    Zhang H; Hollis CP; Zhang Q; Li T
    Int J Pharm; 2011 Aug; 415(1-2):293-300. PubMed ID: 21679755
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preparation and characterization of water-soluble albumin-bound curcumin nanoparticles with improved antitumor activity.
    Kim TH; Jiang HH; Youn YS; Park CW; Tak KK; Lee S; Kim H; Jon S; Chen X; Lee KC
    Int J Pharm; 2011 Jan; 403(1-2):285-91. PubMed ID: 21035530
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improved tumor targeting and antitumor activity of camptothecin loaded solid lipid nanoparticles by preinjection of blank solid lipid nanoparticles.
    Jang DJ; Moon C; Oh E
    Biomed Pharmacother; 2016 May; 80():162-172. PubMed ID: 27133053
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Camptothecin delivery systems: enhanced efficacy and tumor accumulation of camptothecin following its conjugation to polyethylene glycol via a glycine linker.
    Conover CD; Greenwald RB; Pendri A; Gilbert CW; Shum KL
    Cancer Chemother Pharmacol; 1998; 42(5):407-14. PubMed ID: 9771956
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chitosan stabilized camptothecin nanoemulsions: Development, evaluation and biodistribution in preclinical breast cancer animal mode.
    Natesan S; Sugumaran A; Ponnusamy C; Thiagarajan V; Palanichamy R; Kandasamy R
    Int J Biol Macromol; 2017 Nov; 104(Pt B):1846-1852. PubMed ID: 28545970
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hydroxyethyl starch conjugates for improving the stability, pharmacokinetic behavior and antitumor activity of 10-hydroxy camptothecin.
    Li G; Li Y; Tang Y; Zhang Y; Zhang Y; Yin T; Xu H; Cai C; Tang X
    Int J Pharm; 2014 Aug; 471(1-2):234-44. PubMed ID: 24861941
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preparation, formula optimization and antitumor actions of mannitol coupling camptothecin nanoparticles.
    Wang Z; Li Q; Zhao X; Sun B; Zhu Q; Gao W; Hua C
    Int J Pharm; 2014 Apr; 465(1-2):360-7. PubMed ID: 24530520
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SN38 polymeric nanoparticles: in vitro cytotoxicity and in vivo antitumor efficacy in xenograft balb/c model with breast cancer versus irinotecan.
    Sepehri N; Rouhani H; Tavassolian F; Montazeri H; Khoshayand MR; Ghahremani MH; Ostad SN; Atyabi F; Dinarvand R
    Int J Pharm; 2014 Aug; 471(1-2):485-97. PubMed ID: 24879937
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel anti-tumor strategy: PEG-hydroxycamptothecin conjugate loaded transferrin-PEG-nanoparticles.
    Hong M; Zhu S; Jiang Y; Tang G; Sun C; Fang C; Shi B; Pei Y
    J Control Release; 2010 Jan; 141(1):22-9. PubMed ID: 19735683
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lipid nanoparticles loaded with 7-ethyl-10-hydroxycamptothecin-phospholipid complex: in vitro and in vivo studies.
    Liu H; Lu H; Liao L; Zhang X; Gong T; Zhang Z
    Drug Deliv; 2015; 22(6):701-9. PubMed ID: 24625262
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High Drug Loading, Reversible Disulfide Core-Cross-Linked Multifunctional Micelles for Triggered Release of Camptothecin.
    Ling L; Ismail M; Du Y; Xia Q; He W; Yao C; Li X
    Mol Pharm; 2018 Dec; 15(12):5479-5492. PubMed ID: 30376635
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preparation of camptothecin-loaded polymeric micelles and evaluation of their incorporation and circulation stability.
    Watanabe M; Kawano K; Yokoyama M; Opanasopit P; Okano T; Maitani Y
    Int J Pharm; 2006 Feb; 308(1-2):183-9. PubMed ID: 16324807
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transferrin coupled vesicular system for intracellular drug delivery for the treatment of cancer: development and characterization.
    Vaidya B; Vyas SP
    J Drug Target; 2012 May; 20(4):372-80. PubMed ID: 22339366
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Camptothecin in sterically stabilized phospholipid micelles: a novel nanomedicine.
    Koo OM; Rubinstein I; Onyuksel H
    Nanomedicine; 2005 Mar; 1(1):77-84. PubMed ID: 17292061
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pulmonary targeting microparticulate camptothecin delivery system: anticancer evaluation in a rat orthotopic lung cancer model.
    Chao P; Deshmukh M; Kutscher HL; Gao D; Rajan SS; Hu P; Laskin DL; Stein S; Sinko PJ
    Anticancer Drugs; 2010 Jan; 21(1):65-76. PubMed ID: 19966540
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vivo antitumor activity of camptothecin incorporated in liposomes formulated with an artificial lipid and human serum albumin.
    Watanabe M; Kawano K; Toma K; Hattori Y; Maitani Y
    J Control Release; 2008 May; 127(3):231-8. PubMed ID: 18384903
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.